Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Artificial Intelligence: Ready to Simplify the Auto Claims Workflow
The P&C industry has been buzzing for a while about the emergence of “smart” technology entering the claims workflow—from natural language processing to machine learning and artificial intelligence, the frequent tech talk has left us all bracing for the new paradigm.
Big Picture, Big Success
Catastrophic Case Management Meet Lisa Armstrong, BSN, CRRN, RN-BC, CCM Lisa Armstrong has been a
Top Five Reasons You’ll Love DMEC 18
Can’t-miss events abound at this year’s premier disability conference
StateWatch: Bill Review June/July 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
CCMC Elects Chikita Mann to Secretary Post
Genex Supervisor to Serve on the Commissioners' Executive CommitteeWAYNE, PA – July 25, 2018
Mitchell 2019 mPower Conference
Join u